Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast: The role of preoperative mammograms in guiding treatment
- 15 July 1994
- Vol. 74 (2) , 640-647
- https://doi.org/10.1002/1097-0142(19940715)74:2<640::aid-cncr2820740216>3.0.co;2-v
Abstract
Background. The authors have reviewed their institution's experience with conservative surgery and radiation therapy for early stage breast cancer with the goal of defining the impact of infiltrating lobular histology (ILC) on the local recurrence rate. Also, they have examined the preoperative mammograms of the ILC patients to determine if mammographic features could be used to predict treatment outcome. Methods.Between January 1, 1980, and December 31, 1987, 402 cases of Stages I and II breast cancer were treated with conservative surgery and radiation therapy (BCT) at William Beaumont Hospital. Each patient had at least an excisional biopsy. Radiation consisted of 45–50 Gy to the entire breast followed by a supplemental boost dose, so that a minimum of 60 Gy was delivered to the tumor bed. Thirty cancers were classified histologically as infiltrating lobular carcinoma (ILC), 346 as infiltrating ductal carcinoma (IDC), and 26 as other. Median followup is 60 months. Results There was no significant differnce in 5 year actuarial local recurrence rates between ILC and IDC, 3. 3. versus 4. 2%, respectively, (P = not significant). Preoperative mammograms were retrospectively reviewed for 29 of the 30 ILC patients. A spiculated opacity was the most common primary mammographic finding (63%), followed by architectural distortion (17%), poorly defined opacity (7%), and negative (7%). Of the patients who had a preoperative primary mammographic finding of a spiculated opacity, 55% underwent reexcision after the initial excisional biopsy, and residual invasive carcinoma was found in 18% of the reexcision specimens. In contrast, of the patients with a primary mammographic finding of an architectural distortion, poorly defined opacity, or negative, 89% underwent reexcision after an initial excisional biopsy, and residual invasive carcinoma was found in 100% of the reexcision specimens. Conclusions. Infiltrating lobular carcinoma does not have a worse local recurrence rate compared with IDC when each is treated with breast‐conserving therapy. The primary finding on preoperative mammograms in patients with ILC may prove to be a useful tool for predicting the likelihood of residual carcinoma in the breast after initial excisional biopsy. Cancer 1994; 74: 640‐47Keywords
This publication has 29 references indexed in Scilit:
- Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute.Journal of Clinical Oncology, 1992
- Conservation therapy for invasive lobular carcinoma of the breastCancer, 1992
- Treatment of Early-Stage Breast CancerJAMA, 1991
- Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapyRadiotherapy and Oncology, 1990
- Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-upInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Conservation therapy for breast cancers other than infiltrating ductal carcinomaCancer, 1989
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989
- Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancerRadiotherapy and Oncology, 1989
- Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: Long-term resultsEuropean Journal of Cancer and Clinical Oncology, 1986
- Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-RoussyInternational Journal of Radiation Oncology*Biology*Physics, 1985